Marken Offers Exclusive GPS Technology for Shipments
News Aug 20, 2015
Marken has entered into an exclusive agreement with OnAsset Intelligence Inc. for use of their most advanced GPS tracking device on key shipments. The device will significantly improve Marken’s real-time, track and trace capability through custom-designed software.
Marken will offer clients a continuous, shipment-specific device which will track the location of each shipment in real time. In addition to reporting its location, the device will report its temperature, motion & shock, light exposure (open box), atmospheric pressure and remaining battery life.
Marken will also offer geo-fencing at all airports and can customize geo-fence waypoints and status updates for each validated shipping lane. The device transmits in real time and communicates through customized cloud based software. The device and software are protected by over 15 approved patents and is approved for use on more than 40 airlines.
Marken made the decision to take this step to further demonstrate the company’s commitment to high value clinical trial drug substance and drug product which are increasingly derived from sensitive biologic material.
Marken’s Chief Executive Officer, Wes Wheeler, commented on the announcement. “Marken believes that by offering this state-of-the-art tracking device, we have taken an important and necessary step which guarantees the safe delivery of each drug shipment. Marken is committed to providing the latest technology available, and we believe we have found it with OnAsset. Our agreement with OnAsset also comes at an important time in our industry, where GDP compliance is becoming a mandate in our industry. It also allows us to comply with recent updates to Annex 15 in Europe.”
Adam Crossno, OnAsset Intelligence Chief Executive Officer adds, “We are very excited to be working with Marken. OnAsset’s SENTRY FlightSafe® devices, Vision Platform and real time tracking and monitoring across all modes of transport combined with Marken’s industry-leading services and Maestro software are a powerful solution that is unmatched in the marketplace. Being part of the Marken team that is providing a holistic suite of services that offers compliance with global regulations, security and real time validation for such important shipments is game changing. We look forward to showing the world the combined power of real time technology and logistics service excellence.”
Huntsman Cancer Institute Joins National Clinical Trial Targeting AMLNews
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society (LLS). The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.READ MORE
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018